Infective endocarditis in intravenous drug abusers and HIV-1 infected patients

Infectious Disease Clinics of North America

Volumn 16, Issue 2, 2002, Pages 273-295

  Miró, José M ^a,b,c   Del Río, Ana ^a   Mestres, Carlos A ^a,b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLOXACILLIN; FLUCONAZOLE; GENTAMICIN; NAFCILLIN; PENICILLIN G; RIFAMPICIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; DIAGNOSTIC PROCEDURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MORTALITY; PREVALENCE; PROGNOSIS; REVIEW; STAPHYLOCOCCUS AUREUS; TRICUSPID VALVE; VIRUS TRANSMISSION; CONGENITAL MALFORMATION; DRUG COMBINATION; FEMALE; HEART VALVE; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; PATHOGENICITY; PATHOLOGY; RADIOGRAPHY; RISK FACTOR; SUBSTANCE ABUSE; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; FEMALE; HEART VALVE DISEASES; HEART VALVES; HIV INFECTIONS; HIV-1; HUMANS; MALE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 0036086438     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(01)00008-3     Document Type: Review

References (123)

1. Epidemiology and control of AIDS among drug users
2. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 Years later
3. Estudio multicéntrico de las complicaciones infecciosas en adictos a drogas por vía parenteral en España: Análisis final de 17.592 casos (1977-1991)
4. Serious infections other than human immunodeficiency virus among intravenous drug abusers
5. Infective endocarditis and other vascular infections in intravenous drug abusers
6. Endocarditis complicating parenteral drug abuse
7. Selective survival in pentazocine and tripelennamine of Pseudomonas aeruginosa serotype 011 from drug addicts
8. Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors and empiric therapy
9. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: A prospective comparative study
10. Outbreak of endocarditis caused by Pseudomonas aeruginosa serotype 011 amount pentazocine and tripelennamine abusers in Chicago
11. Disseminated candidiasis in addicts who use brown heroin: Report of 83 cases and review
12. Infections in injection drug users
13. Infective endocarditis (IE) in Spanish IV drug addicts (IVDA): Analysis of 1.529 episodes (1978-1993)
14. Infective endocarditis in the narcotic addict
15. Endocarditis in intravenous drug users
16. Infectious complications in drug addicts: Seven-year review of 269 hospitalized narcotic abusers in Switzerland
17. A larger spectrum of severe HIV-1 related disease in intravenous drug users in New York City
18. Medical disorders in drug addicts. 200 Consecutive admissions
19. Endocarditis infecciosa. Tratado de Medicina Interna
20. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users
21. Cocaine use and the risk of endocarditis in intravenous drug abusers
22. A review of endocarditis in acquired immunodeficiency syndrome and human immunodeficiency virus infection
23. Decrease in the annual frequency of infectious endocarditis among intravenous drug users in southern Spain
24. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users
25. Síndrome de Austrian e infección por el virus de la inmunodeficiencia humana
26. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center
27. Serratia marcescens endocarditis: A regional illness associated with intravenous drug abuse
28. Subacute and acute endocarditis due to Pseudomonas cepacia in heroin addicts
29. Enterococcal endocarditis in heroin addicts
30. Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich
31. Infective endocarditis following human to human enterococcal transmission. A complication of intravenous narcotic abuse
32. Endocarditis from human to human transmission of Staphylococcus aureus
33. Estudio de la tasa de portadores cutaneomucosos de estafilococos en heroinómanos del área de Barcelona y de las caracteristicas microbiológicas de la heroína y material de inyección
34. Increased rate of carriage of Staphylococcus aureus among narcotic addicts
35. Staphylococcal endocarditis in parenteral drug abusers: Source of the organism
36. Bacterial infections and skin cleaning prior to injection among intravenous drug users
37. Microbiological study of street heroin and injection paraphernalia
38. Antimicrobial activity of street heroin
39. Source of the infection in an outbreak of systemic candidiasis in Spanish heroin addicts
40. Intravenous drug use and infective endocarditis: Report from the ICE investigators
41. Infective endocarditis in drug addicts
42. Right-side endocarditis in injection drug users: Review of proposed mechanisms of pathogenesis
43. Septic pulmonary emboli. A rare cause of bilateral pneumothorax in drug abusers
44. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings
45. The febrile parenteral drug user: A prospective study in 121 patients
46. Improvement in the diagnosis of abscesses associated with endocarditis by tranesophageal echocardiography
47. Echocardiography in infective endocarditis: Reassessment of prognostic implications of vegetattions size determined by the transthoracic and the transesophageal approach
48. Tricuspid valve endocarditis to Staphylococcus aureus correlation of two dimensional echocardiography with clinical outcome
49. Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes
50. Echocardiographic and clinical correlates in drug addicts with infective endocarditis. Implications of vegetations size
51. Transesophageal echocardiography in right-sided endocarditis
52. Endocarditis infecciosa en heroinónamos en la provincia de Cádiz. Un estudio multicéntrico sobre 150 episodios
53. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection
54. Results of surgical treatment for infective endocarditis in intravenous drug users
55. Six-year experience with cryopreserved mitral homografts in the treatment of tricuspid valve endocarditis in HIV-infected drug addicts
56. Staphylococcal endocarditis-recommendations for therapy
57. New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis
58. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci and HACEK microorganisms
59. Antibiotic treatment of infective endocarditis due to viridans streptococci, enterococci and other streptococci
60. Antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis
61. Short-course combination and oral therapies of Staphylococcus aureus endocarditis
62. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users
63. Valve-site specific pathogenic differences between right-sided and left-sided bacterial endocarditis
64. Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of polyethylene catheter in the right side of the heart
65. Experimental endocarditis II. Staphylococcal endocarditis of the aortic valve following placement of a polyethylene catheter in the left side of the heart
66. Experimental endocarditis III. Natural history of catheter induced staphylococcal endocarditis following catheter removal
67. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus
68. Nafcillin-gentamycin synergism in experimental staphylococcal endocarditis
69. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: Two-week combination therapy
70. Right-sided endocarditis caused by Staphylococcus aureus in parenteral drug addicts: Evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment
71. Right-sided endocarditis caused by Staphylococcus aureus in drug abusers
72. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: Cloxacillin versus glycopeptides in combination with gentamicin
73. Effectiveness of cloxacillin with or without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis: A randomized, controlled trial
74. Indications and therapeutic results of an antibiotic regimen lasting two weeks in intravenous drug users with right-sided S. aureus infective endocarditis: A multicentre study of 139 consecutive cases
75. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study
76. Right-sided endocarditis with Staphylococcus aureus
77. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug abusers
78. Treatment of right-sided S. aureus endocarditis in intravenous drug abusers with ciprofloxacin and rifampicin
79. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapy
80. Early resistance to rifampin and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis
81. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis
82. Evaluation of antibiotic difussion into cardiac vegetations by quantitative autoradiography
83. Vancomycin pharmacokinetics in burn patients and intravenous drug abusers
84. Teicopllanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis
85. Gram-negative bacterial endocarditis
86. Indications for cardiac surgery in patients with active infective endocarditis
87. Recommendations for the surgical treatment of endocarditis
88. Surgical treatment of intractable right-sided endocarditis in drug addicts: 25 Years' experience
89. Endocarditis in intravenous drug addicts and HIV infected patients: Possibilities and limitations of surgical treatment
90. Total tricuspid valvulectomy without replacement in the treatment of pseudomonas endocarditis
91. Valvulectomy without prosthetic replacement. A lifesaving operation for tricuspid pseudomonas endocarditis
92. Tricuspid valvulectomy without prosthetic replacement. Ten years of clinical experience
93. Tricuspid valvulectomy without replacement. Twenty years' experience
94. Tricuspid valve replacement using a mitral homograft. Surgical technique and initial results
95. Tricuspid valve replacement using a cryopreserved mitral homograft. Surgical technique and initial results
96. Management of persistent tricuspid endocarditis with transplantation of cryopreserved mitral homografts
97. Infective endocarditis in intravenous drug users: A comparison of human immunodeficiency virus type 1-negative and -positive patients
98. Infective endocarditis in injection drug users: Importance of human immunodeficiency virus serostatus and degree of immunosupression
99. Influence of human immunodeficiency virus 1 infection an degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users
100. Estudio de 164 episodios de endocarditis infecciosa en drogadictos: Comparación entre pacientes VIH positivos y negativos
101. Cardiopulmonary bypass in HIV-positive patients
102. Cardiac surgery in HIV-positive intravenous drug addicts: Influence of cardiovascular bypass on the progression to AIDS
103. Human immunodeficiency virus infection and infective endocarditis among injecting drug users
104. Incidence and spectrum of severe medical complications among hospitalized HIV-seronegative and HIV-seropositive narcotic drug users
105. HTLV-II and bacterial infections among injection drug users
106. Infective endocarditis in intravenous drug users: Does HIV status alter the presenting temperature and white blood cell count?
107. Infective endocarditis in HIV-infected patients without active IV drug addiction: Review of 24 episodes
108. Infective endocarditis in non-intravenous drug users: A comparison of HIV-positive and HIV-negative patients a report from the ICE investigators
109. Cardiac manifestations of acquired immunodeficiency syndrome
110. Cardiac manifestations of HIV/AIDS: A review of disease spectrum and clinical management
111. Aspergillus endocarditis and myocarditis in a patient with the acquired immunodeficiency syndrome (AIDS). A review of the literature
112. Infectious endocarditis due to non-typhy Salmonella in patients infected with human immunodeficiency virus: Report of two cases and review
113. Anomalies échocardiographiques au stade IV de ĺinfection par le VIH
114. Treatment of AIDS-associated heart disease
115. AIDS and the heart: Review and consideration of pathogenetic mechanisms
116. Endocarditis neumocócica y neumonia por Pneumocystis carinii en un paciente con infección por VIH
117. Opportunistic infections and Kaposi's sarcoma among Haitians: Evidence of a new acquired immunodeficiency state
118. Native valve endocarditis due to Pseudallescheria boydii in a patient with AIDS: Case report and review
119. Endocarditis due to Listeria monocytogenes and human immunodeficiency virus infection
120. Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus
121. Endocarditis candidiásica tardía sobre prótesis en paciente positivo para VIH. Buena evolución tras tratamiento
122. Case report: Candida zeylanoides infective endocarditis complicating infection with the human immunodeficiency virus